These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29634701)

  • 1. Tacrolimus versus Cyclosporine- Comparative Evaluation as First line drug in Vernal keratoconjuctivitis.
    Kumari R; Saha BC; Sinha BP; Mohan N
    Nepal J Ophthalmol; 2017 Jul; 9(18):128-135. PubMed ID: 29634701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q; Tang J; Han Y; Wang D; Ye H
    Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
    Pucci N; Caputo R; di Grande L; de Libero C; Mori F; Barni S; di Simone L; Calvani A; Rusconi F; Novembre E
    Pediatr Allergy Immunol; 2015 May; 26(3):256-261. PubMed ID: 25712437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
    Vichyanond P; Kosrirukvongs P
    Curr Allergy Asthma Rep; 2013 Jun; 13(3):308-14. PubMed ID: 23625179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.
    Malhotra C; Singh H; Jain AK; Gupta A; Ram J
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1083-1091. PubMed ID: 33764241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
    Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
    Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ocular cytology in vernal keratoconjunctivitis.
    Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
    Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
    Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial.
    Keklikci U; Dursun B; Cingu AK
    Adv Clin Exp Med; 2014; 23(3):455-61. PubMed ID: 24979519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.
    Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S
    Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.
    Westland T; Patryn EK; Nieuwendaal CP; van der Meulen IJE; Mourits MP; Lapid-Gortzak R
    Int Ophthalmol; 2018 Feb; 38(1):363-368. PubMed ID: 28120172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis.
    Ryu EH; Kim JM; Laddha PM; Chung ES; Chung TY
    Korean J Ophthalmol; 2012 Aug; 26(4):241-7. PubMed ID: 22870021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Safety and Efficacy of Tacrolimus 0.1% in Severe Pediatric Vernal Keratoconjunctivitis.
    Caputo R; Marziali E; de Libero C; Di Grande L; Danti G; Virgili G; Villani E; Mori F; Bacci GM; Lucenteforte E; Pucci N
    Cornea; 2021 Nov; 40(11):1395-1401. PubMed ID: 34029239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reserve drug as first-line management: Topical interferon α-2b for vernal keratoconjunctivitis.
    Haral SR; Khan T; Gupta VS; Ukalkar MS
    Indian J Ophthalmol; 2024 Jul; 72(7):1007-1011. PubMed ID: 38454855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis].
    Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M
    Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis.
    Yücel OE; Ulus ND
    Singapore Med J; 2016 Sep; 57(9):507-10. PubMed ID: 26768065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis].
    Takamura E; Uchio E; Ebihara N; Okamoto S; Kumagai N; Shoji J; Nakagawa Y; Namba K; Fukushima A; Fujishima H; Miyazaki D; Ohashi Y
    Nippon Ganka Gakkai Zasshi; 2011 Jun; 115(6):508-15. PubMed ID: 21735754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.